Cross, Alan S <br/><br/>
Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis.  [electronic resource] 

 -  Vaccine  Nov 2015 
 - 6719-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2015.10.072  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Adult<br/>Antibodies, Bacterial--blood<br/>Bacterial Outer Membrane Proteins--administration & dosage<br/>Cohort Studies<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Humans<br/>Immunoglobulin G--blood<br/>Immunoglobulin M--blood<br/>Lipopolysaccharides--administration & dosage<br/>Male<br/>Meningococcal Infections--prevention & control<br/>Meningococcal Vaccines--administration & dosage<br/>Middle Aged<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Sepsis--prevention & control<br/>Treatment Outcome<br/>Young Adult